Skip to main content
SpringerLink
Log in

Mycobacteriosis and Nocardiosis in the Immunocompromised Host

  • Chapter
Clinical Approach to Infection in the Compromised Host

Abstract

The history of tuberculosis abounds with theories of disease causation, of which most fit neatly into one of two conceptual frameworks: (1) theories of contagion in which the illness derives from a transmissible agent or substance and (2) explanations based on the notion of an inherited or acquired predisposition to tuberculosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Flint A: A Treatise on the Principles and Practice of Medicine, 5th ed. Henry C. Lea’s Son, Philadelphia, 1881, p. 205.

    Google Scholar 

  2. Flint A: A Treatise on the Principles and Practice of Medicine, 5th ed. Henry C. Lea’s Son, Philadelphia, 1881, p. 208.

    Google Scholar 

  3. Koch R: The aetiology of tuberculosis. Berliner Klin Wochenschr 19: 221, 1882; National Tuberculosis Association, New York (translated by Dr and Mrs M Pinner), 1932.

    Google Scholar 

  4. Koch R: The aetiology of tuberculosis. Berliner Klin Wochenschr 19: 221, 1882; National Tuberculosis Association, New York, 1932 (translated by Dr and Mrs M Pinner), p. 31.

    Google Scholar 

  5. Flint A: A Treatise on the Principles and Practice of Medicine, 6th ed. Henry C. Lea’s Son, Philadelphia, 1886, pp. 194–195.

    Google Scholar 

  6. Nocard E: Note sur la maladie de boeufs de la Guadeloupe, connue sous le nom de farçin. Ann Inst Pasteur Paris 2: 293–302, 1888.

    Google Scholar 

  7. Waksman SA, Henrici AT: The nomenclature and classification of the Actinomycetes. J Bacteriol 46: 337–341, 1943.

    PubMed  CAS  Google Scholar 

  8. Runyon EH: Anonymous mycobacteria in pulmonary disease. Med Clin North Am 43: 273–290, 1959.

    PubMed  CAS  Google Scholar 

  9. Pierce PF, DeYoung DR, Roberts GD: Mycobacteremia and the new blood culture systems. Ann Intern Med 99: 786–789, 1983.

    PubMed  CAS  Google Scholar 

  10. Witebsky FG, Reiser JF, Conville PS, et al: Comparison of BACTEC 13A medium and Du Pont Isolator for the detection of mycobacteremia. J Clin Microbiol 26: 1501–1505, 1988.

    PubMed  CAS  Google Scholar 

  11. Gill VJ, Park CH, Stock F, et al: Use of lysis-centrifugation (Isolator) and radiometric (BACTEC) blood culture systems for the detection of mycobacteremia. J Clin Microbiol 22: 543–546, 1985.

    PubMed  CAS  Google Scholar 

  12. Kiehn TE, Gold JWM, Brannon P, et al: Mycobacterium tuberculosis bacteremia detected by the Isolator lysis-centrifugation blood culture system. J Clin Microbiol 26: 760–761, 1988.

    PubMed  CAS  Google Scholar 

  13. Drake TA, Hindier JA, Berlin OGW, et al: Rapid identification of Mycobacterium avium complex in culture using DNA probes. J Clin Microbiol 25: 1442–1445, 1987.

    PubMed  CAS  Google Scholar 

  14. Gonzalez R, Hanna BA: Evaluation of Gen-Probe DNA hybridization systems for the identification of Mycobacterium tuberculosis and Mycobacterium avium—intracellulare. Diagn Microbiol Infect Dis 8: 69–78, 1987.

    PubMed  CAS  Google Scholar 

  15. Kiehn TE, Edwards FF: Rapid identification using a specific DNA probe of Mycobacterium avium complex from patients with acquired immunodeficiency syndrome. J Clin Microbiol 25: 1551–1552, 1987.

    PubMed  CAS  Google Scholar 

  16. Musial CE, Tice LS, Stockman L, et al: Identification of mycobacteria from culture by using the Gen-Probe rapid diagnostic system for Mycobacterium avium complex and Mycobacterium tuberculosis complex. J Clin Microbiol 26: 2120–2123, 1988.

    PubMed  CAS  Google Scholar 

  17. Smith JA, Reichman LB: Lymphocyte transformation: An aid in the diagnosis of tuberculosis in patients with nonreactive skin tests. Am Rev Respir Dis 106: 194–201, 1972.

    PubMed  CAS  Google Scholar 

  18. Nassau E, Parsons ER, Johnson GD: The detection of antibodies to Mycobacterium tuberculosis by microplate enzyme-linked immunosorbent assay (ELISA). Tubercle 57: 67–70, 1976.

    PubMed  CAS  Google Scholar 

  19. Daniel TM, Debanne SM: The serodiagnosis of tuberculosis and other mycobacterial diseases by enzyme-linked immunosorbent assay. Am Rev Respir Dis 135: 1137–1151, 1987.

    PubMed  CAS  Google Scholar 

  20. Pang JA, Chan HS, Chan CY, et al: A tuberculostearic acid assay in the diagnosis of sputum smear-negative pulmonary tuberculosis. Ann Intern Med 111: 650–654, 1989.

    PubMed  CAS  Google Scholar 

  21. Brisson-Noel A, Lecossier D, Nassif X, et al: Rapid diagnosis of tuberculosis by amplification of mycobacterial DNA in clinical samples. Lancet 2: 1069–1071, 1979.

    Google Scholar 

  22. Koch R: Fortsetzung der Mitteilungen über ein Heilmittel gegen Tuberculose. Dtsch Med Wochenschr 17: 101, 1891; in Lancet 1: 168-169, 1891.

    Google Scholar 

  23. Seibert FB, Glenn JT: Tuberculin purified protein derivative: Preparation and analyses of a large quantity for standard. Am Rev Tuberc 44: 9–25, 1941.

    CAS  Google Scholar 

  24. Ellner JJ: Suppressor adherent cells in human tuberculosis. J Immunol 121: 2573–2579, 1978.

    PubMed  CAS  Google Scholar 

  25. Sahn SA, Neff TA: Miliary tuberculosis. Am J Med 56: 495–505, 1974.

    Google Scholar 

  26. Slavin RE, Walsh TJ, Pollack AD: Late generalized tuberculosis: A clinical pathologic analysis and comparison of 100 cases in the preantibiotic and antibiotic eras. Medicine (Baltimore) 59: 352–366, 1980.

    CAS  Google Scholar 

  27. Ferebee S, Mount F: Evidence of booster effect in serial tuberculin testing. Am Rev Respir Dis 88: 118–119, 1963.

    Google Scholar 

  28. Snider DE: The tuberculin skin test. Am Rev Respir Dis 125: 108–117, 1982.

    PubMed  Google Scholar 

  29. CDC: Screening for tuberculosis and tuberculous infection in high-risk populations. Morb Mortal Wkly Rep 39(RR-8): 1–7, 1990.

    Google Scholar 

  30. Riley RL, Mills CC, O’Grady F, et al: Infectiousness of air from a tuberculosis ward: Comparative infectiousness of different patients. Am Rev Respir Dis 84: 511–525, 1962.

    Google Scholar 

  31. Riley RL: Disease transmission and contagion control. Am Rev Respir Dis 125: 16–19, 1982.

    PubMed  CAS  Google Scholar 

  32. Dannenberg AM: Immune mechanisms in the pathogenesis of pulmonary tuberculosis. Rev Infect Dis 11: S369–S378, 1989.

    PubMed  Google Scholar 

  33. Stead WW: Pathogenesis of tuberculosis: Clinical and epidemiologic perspective. Rev Infect Dis 11: S366–S368, 1989.

    PubMed  Google Scholar 

  34. Grzyboswki S, Allen EA: The challenge of tuberculosis in decline: A study based on the epidemiology of tuberculosis in Ontario, Canada. Am Rev Respir Dis 90: 707–720, 1964.

    Google Scholar 

  35. Nardell E, McInnis B, Thomas B, et al: Exogenous reinfection with tuberculosis in a shelter for the homeless. N Engl J Med 315: 1570–1575, 1986.

    PubMed  CAS  Google Scholar 

  36. Piessens WF: Introduction to the immunology of tuberculosis. Rev Infect Dis 11: S436–S442, 1989.

    PubMed  Google Scholar 

  37. Kaufmann SHE: In vitro analysis of the cellular mechanisms involved in immunity to tuberculosis. Rev Infect Dis 11: S448–S454, 1989.

    PubMed  Google Scholar 

  38. Stead WW: Pathogenesis of the sporadic case of tuberculosis. N Engl J Med 277: 1008–1012, 1967.

    PubMed  CAS  Google Scholar 

  39. Daniel T: Tuberculosis. Rev Infect Dis 4: 93–105, 1982.

    Google Scholar 

  40. Karlson AG, Carr DT: Tuberculosis caused by Mycobacterium bovis: Report of six cases 1954-1968. Ann Intern Med 73: 979–983, 1970.

    PubMed  CAS  Google Scholar 

  41. Wilkins EGL, Griffiths RJ, Roberts C: Pulmonary tuberculosis due to Mycobacterium bovis. Thorax 41: 685–687, 1986.

    PubMed  CAS  Google Scholar 

  42. Thomas DA, Mines JS, Thomas DE, et al: Armadillo exposure among Mexican-born patients with lepromatous leprosy. J Infect Dis 156: 990–992, 1987.

    PubMed  CAS  Google Scholar 

  43. Drutz DJ, Chen TSN Lu WH: The continuous bacteremia of lepromatous leprosy. N Engl J Med 287: 159–164, 1972.

    PubMed  CAS  Google Scholar 

  44. West BC, Todd JR, Lary CH, et al: Leprosy in six isolated residents of northern Louisiana: Time-clustered cases in an essentially nonendemic area. Arch Intern Med 148: 1987–1992, 1988.

    PubMed  CAS  Google Scholar 

  45. Fleming AF: Opportunistic infections in AIDS in developed and developing countries. Trans R Soc Trop Med Hyg 84(Suppl 1): 1–6, 1990.

    PubMed  Google Scholar 

  46. Wolinsky E: Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 119: 107–159, 1979.

    PubMed  CAS  Google Scholar 

  47. Woods GL, Washington JA: Mycobacteria other than Mycobacterium tuberculosis: Review of microbiologic and clinical aspects. Rev Infect Dis 9: 275–294, 1987.

    PubMed  CAS  Google Scholar 

  48. Edwards LV, Acquaviva FA, Livesay VT, et al: An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 99: 1–131, 1969.

    PubMed  Google Scholar 

  49. Wallace RJ, Swenson JM, Silcox VA, et al: Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 5: 657–679, 1983.

    PubMed  Google Scholar 

  50. Horsburgh CR, Mason UG, Farhi DC, et al: Disseminated infection with Mycobacterium avium—intracellulare: A report of 13 cases and a review of the literature. Medicine (Baltimore) 64: 36–48, 1985.

    Google Scholar 

  51. Yamamoto M, Ogura Y, Sudo K, et al: Diagnostic criteria for disease caused by atypical mycobacteria. Am Rev Respir Dis 96: 773–778, 1967.

    PubMed  CAS  Google Scholar 

  52. Roberts GD, Koneman EW, Kim YK: Mycobacterium. In Hausier WJ, Kerrmann KL, Isenberg HD, et al (eds): Manual of Clinical Microbiology. American Society for Microbiology, Washington DC, 1991, pp. 304–339.

    Google Scholar 

  53. Crow HE, King CT, Smith CE, et al: A limited clinical, pathologic, and epidemiologic study of patients with pulmonary lesions associated with atypical acid-fast bacilli in the sputum. Am Rev Tuberc 75: 199–222, 1957.

    PubMed  CAS  Google Scholar 

  54. Iseman MD, Corpe RF, O’Brien RJ, et al: Disease due to Mycobacterium avium-intracellulare. Chest 87: 139S–149S, 1985.

    PubMed  CAS  Google Scholar 

  55. O’Brien RJ, Geiter LJ, Snider DE: The epidemiology of non-tuberculous mycobacterial diseases in the United States: Results from a national survey. Am Rev Respir Dis 135: 1007–1014, 1987.

    PubMed  Google Scholar 

  56. Iseman MD: Mycobacterium avium complex and the normal host: The other side of the coin. N Engl J Med 321: 896–898, 1989.

    PubMed  CAS  Google Scholar 

  57. Edwards LB, Acquaviva FA, Livesay VT, et al: An atlas of sensitivity to tuberculin, PPD-B and histoplasmin in the United States. Am Rev Respir Dis 99: 1–131, 1969.

    PubMed  Google Scholar 

  58. Falkinham JO, Parker BC, Gruft H: Epidemiology of infection by nontuberculous mycobacteria. I. Geographic distribution in the Eastern United States. Am Rev Respir Dis 121: 931–937, 1980.

    PubMed  Google Scholar 

  59. Meissner PS, Falkinham JO: Plasmid DNA profiles as epidemio-logical markers for clinical and environmental isolates of Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum. J Infect Dis 153: 325–331, 1986.

    PubMed  CAS  Google Scholar 

  60. Prince DS, Peterson DD, Steiner RM, et al: Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 321: 863–868, 1989.

    PubMed  CAS  Google Scholar 

  61. Lai KK, Stottmeier KD, Sherman IH, et al: Mycobacterial cervical lymphadenopathy: Relation of etiologic agents to age. JAMA 251: 1286–1288, 1984.

    PubMed  CAS  Google Scholar 

  62. Kinsella JP, Culver K, Jeffrey RB, et al: Extensive cervical lymphadenitis due to Mycobacterium avium—intracellulare. Pediatr Infect Dis 6: 289–291, 1987.

    CAS  Google Scholar 

  63. Yeager H, Raleigh JW: Pulmonary disease due to Mycobacterium intracellulare. Am Rev Respir Dis 108: 547–552, 1973.

    PubMed  Google Scholar 

  64. Rosenzweig DY: Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex: Clinical features and course in 100 consecutive cases. Chest 75: 115–119, 1979.

    PubMed  CAS  Google Scholar 

  65. Rosenzweig DY, Schlueter DP: Spectrum of clinical disease in pulmonary infection with Mycobacterium avium—intracellulare. Rev Infect Dis 3: 1046–1051, 1981.

    PubMed  CAS  Google Scholar 

  66. Listwan WJ, Roth DA, Tsung SH, et al: Disseminated Mycobacterium kansasii infection with pancytopenia and interstitial nephritis. Ann Intern Med 83: 70–73, 1975.

    PubMed  CAS  Google Scholar 

  67. Kilbridge TM, Gonella JS, Bolan JT: Pancytopenia and death: Disseminated anonymous mycobacterial infection. Arch Intern Med 120: 38–46, 1967.

    PubMed  CAS  Google Scholar 

  68. Scherer R, Sable R, Sonnenberg M, et al: Disseminated infection with Mycobacterium kansasii in the acquired immunodeficiency syndrome. Ann Intern Med 105: 710–712, 1986.

    Google Scholar 

  69. Bennett C, Vardiman J, Golomb H: Disseminated atypical mycobacterial infection in patients with hairy cell leukemia. Am J Med 80: 891–896, 1986.

    PubMed  CAS  Google Scholar 

  70. Pottage JC, Harris AA, Trenholme GM, et al: Disseminated Mycobacterium chelonei infection: A report of two cases. Am Rev Respir Dis 126: 720–722, 1982.

    PubMed  Google Scholar 

  71. Azadian BS, Beck A, Curtis JR, et al: Disseminated infection with Mycobacterium chelonei in a hemodialysis patient. Tubercle 62: 281–284, 1981.

    PubMed  CAS  Google Scholar 

  72. Wolinsky E: The role of scotochromogenic mycobacteria in human disease. Ann NY Acad Sci 106: 67–71, 1963.

    PubMed  CAS  Google Scholar 

  73. Contreras MA, Cheung OT, Sanders DE, et al: Pulmonary infection with nontuberculous mycobacteria. Am Rev Respir Dis 137: 149–152, 1988.

    PubMed  CAS  Google Scholar 

  74. Ausina V, Barrio J, Luguin M, et al: Mycobacterium xenopi infections in AIDS. Ann Intern Med 109: 927–928, 1988.

    PubMed  CAS  Google Scholar 

  75. Maloney JM, Gregg CR, Stephens DS, et al: Infections caused by Mycobacterium szulgai in humans. Rev Infect Dis 9: 1120–1126, 1987.

    PubMed  CAS  Google Scholar 

  76. Alberts WM, Chandler KW, Solomon DA, et al: Pulmonary disease caused by Mycobacterium malmoense. Am Rev Respir Dis 135: 1375–1378, 1987.

    PubMed  CAS  Google Scholar 

  77. Levy-Frebault V, Pagnon B, Bure A, et al: Mycobacterium simiae and Mycobacterium avium—M. intracellulare mixed infection in acquired immune deficiency syndrome. J Clin Microbiol 25: 154–157, 1987.

    PubMed  CAS  Google Scholar 

  78. Moulsdale MT, Harper JM, Thatcher GN: Infection by Mycobacterium haemophilum, a metabolically fastidious acid-fast bacillus. Tubercle 64: 29–36, 1983.

    PubMed  CAS  Google Scholar 

  79. Rogers PL, Walker RE, Lane HC, et al: Disseminated Mycobacterium haemophilum infection in two patients with the acquired immune deficiency syndrome. Am J Med 84: 640–642, 1988.

    PubMed  CAS  Google Scholar 

  80. Pitlik SD, Fainstein V, Bodey GP: Tuberculosis mimicking cancer—a reminder. Am J Med 76: 822–825, 1984.

    PubMed  CAS  Google Scholar 

  81. Snider GL: Bronchogenic carcinoma and pulmonary tuberculosis. Dis Chest 55: 181–182, 1969.

    PubMed  CAS  Google Scholar 

  82. Gopalakrishnan P, Miller JE, McLaughlin JS: Pulmonary tuberculosis and coexisting carcinoma: A 10-year experience and review of the literature. Am Surg 41: 405–408, 1975.

    PubMed  CAS  Google Scholar 

  83. Roviaro GC, Sartori F, Calabro F, et al: The association of pleural mesothelioma and tuberculosis. Am Rev Respir Dis 126: 569–571, 1982.

    PubMed  CAS  Google Scholar 

  84. Feld R, Bodey GP, Groschel D: Mycobacteriosis in patients with malignant disease. Arch Intern Med 136: 67–70, 1976.

    PubMed  CAS  Google Scholar 

  85. Kaplan MH, Armstrong D, Rosen P: Tuberculosis complicating neoplastic disease: A review of 201 cases. Cancer 33: 850–858, 1974.

    PubMed  CAS  Google Scholar 

  86. Ortbals DW, Marr JJ: A comparative study of tuberculous and other mycobacterial infections and their associations with malignancy. Am Rev Respir Dis 117: 39–45, 1978.

    PubMed  CAS  Google Scholar 

  87. Lowther CP: Leukemia and tuberculosis. Ann Intern Med 51: 52–56, 1959.

    PubMed  CAS  Google Scholar 

  88. Morrow LB, Anderson RE: Active tuberculosis in leukemia, malignant lymphoma and myelofibrosis. Arch Pathol 79: 484–493, 1965.

    PubMed  CAS  Google Scholar 

  89. Coburn RJ, England JM, Samson DM, et al: Tuberculosis and blood disorders. Br J Haematol 25: 793–799, 1973.

    PubMed  CAS  Google Scholar 

  90. Weinstein RA, Golomb HM, Grumet G, et al: Hairy cell leukemia: Association with disseminated atypical mycobacterial infection. Cancer 48: 380–383, 1981.

    PubMed  CAS  Google Scholar 

  91. Bass JB, Farer LS, Hopewell PC, et al: Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 134: 355–363, 1986.

    Google Scholar 

  92. Fauci AS, Dale DC, Balow JE: Glucocorticosteroid therapy: Mechanisms of action and clinical considerations. Ann Intern Med 84: 304–315, 1976.

    PubMed  CAS  Google Scholar 

  93. Bovornkitti S, Kangsadal P, Sathirpat P, et al: Reversion and reconversion rate of tuberculin skin reactions in correlation with the use of prednisone. Chest 38: 51–55, 1960.

    CAS  Google Scholar 

  94. MacGregor RR, Sheagren JN, Lipsett MB, et al: Alternate day prednisone therapy. N Engl J Med 280: 1427–1431, 1969.

    PubMed  CAS  Google Scholar 

  95. Millar JW, Home NW: Tuberculosis in immunosuppressed patients. Lancet 1: 1176–1178, 1979.

    PubMed  CAS  Google Scholar 

  96. Sahn SA, Lakshminarayan S: Tuberculosis after corticosteroid therapy. Br J Dis Chest 70: 195–205, 1976.

    PubMed  CAS  Google Scholar 

  97. Schatz M, Patterson R, Kloner R: The prevalence of tuberculosis and positive tuberculin skin tests in a steroid-treated asthmatic population. Ann Intern Med 84: 261–265, 1976.

    PubMed  CAS  Google Scholar 

  98. Cowie RL, King LM: Pulmonary tuberculosis in corticosteroidtreated asthmatics. South Afr Med J 72: 849–850, 1987.

    CAS  Google Scholar 

  99. Walsh SD, Grant WB: Corticosteroids in treatment of chronic asthma. Br Med J 2: 796–802, 1966.

    PubMed  CAS  Google Scholar 

  100. Smyllie HC, Connoll CK: Incidence of serious complications of corticosteroid therapy in respiratory disease. Thorax 23: 571–581, 1968.

    PubMed  CAS  Google Scholar 

  101. Fine PEM: The BCG story: Lessons from the past and implications for the future. Rev Infect Dis 11(Suppl 2): S353–S359, 1989.

    PubMed  Google Scholar 

  102. Bast RC, Zbar B, Borsos T, et al: BCG and cancer. N EnglJ Med 290: 1413–1420, 1974.

    Google Scholar 

  103. Sparks FC, Silverstein MJ, Hunt JS, et al: Complications of BCG immunotherapy in patients with cancer. N Engl J. Med 289: 827–830, 1973.

    PubMed  CAS  Google Scholar 

  104. Aungst CW, Sokal JE, Jager BV: Complications of BCG vaccination in neoplastic disease. Ann Intern Med 82: 666–669, 1975.

    PubMed  CAS  Google Scholar 

  105. Rosenberg SA, Seipp C, Sears HF: Clinical and immunologic studies of disseminated BCG infection. Cancer 41: 1771–1780, 1978.

    PubMed  CAS  Google Scholar 

  106. Gonzalez B, Moreno S, Burdach R, et al: Clinical presentation of bacillus Calmette-Guerin infections in patients with immunodeficiency syndromes. Pediatr Infect Dis J 8: 201–206, 1989.

    PubMed  CAS  Google Scholar 

  107. von Reyn CF, Clements CJ, Mann JM: Human immunodeficiency virus infection and routine childhood immunisation. Lancet 2: 669–672, 1987.

    Google Scholar 

  108. CDC: Disseminated Mycobacterium bovis infection from BCG vaccination of a patient with acquired immunodeficiency syndrome. Morb Mortal Wkly Rep 34: 227–228, 1985.

    Google Scholar 

  109. CDC: Use of BCG vaccines in the control of tuberculosis: A joint statement by the ACIP and the advisory committee for elimination of tuberculosis. Morb Mortal Wkly Rep 37: 663–675, 1988.

    Google Scholar 

  110. Au FC, Webber B, Rosenberg SA: Pulmonary granulomas induced by BCG. Cancer 41: 2209–2214, 1978.

    PubMed  CAS  Google Scholar 

  111. Weiss W: Tuberculosis in student nurses at Philadelphia General Hospital. Am Rev Respir Dis 107: 136–139, 1973.

    PubMed  CAS  Google Scholar 

  112. Di Perri G, Danzi MC, De Checchi G, et al: Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet 2: 1502–1504, 1989.

    PubMed  Google Scholar 

  113. CDC: Transmission of multidrug-resistant tuberculosis from an HIV-positive client in a residential substance-abuse treatment facility. Morb Mortal Wkly Rep 40: 129–131, 1991.

    Google Scholar 

  114. CDC: Nosocomial transmission of multidrug-resistant tuberculosis to health-care workers and HIV-infected patients in an urban hospital. Morb Mortal Wkly Rep 39: 718–722, 1990.

    Google Scholar 

  115. Ehrenkranz NJ, Kicklighter JL: Tuberculosis outbreak in a general hospital: Evidence for airborne spread of infection. Ann Intern Med 77: 377–382, 1972.

    PubMed  CAS  Google Scholar 

  116. Catanzaro A: Nosocomial tuberculosis. Am Rev Respir Dis 125: 559–562, 1982.

    PubMed  CAS  Google Scholar 

  117. Kantor HS, Poblete R, Pusateri SL: Nosocomial transmission of tuberculosis from unsuspected disease. Am J Med 84: 833–838, 1988.

    PubMed  CAS  Google Scholar 

  118. Haley CE, McDonald RC, Rossi L, et al: Tuberculosis epidemic among hospital personnel. Infect Control Hosp Epidemiol 10: 204–210, 1989.

    PubMed  CAS  Google Scholar 

  119. Brennen C, Muder RR, Muraca PW: Occult endemic tuberculosis in a chronic care facility. Infect Control Hosp Epidemiol 9: 548–552, 1988.

    PubMed  CAS  Google Scholar 

  120. CDC: Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. Morb Mortal Wkly Rep 39(RR-17): 1–29, 1990.

    Google Scholar 

  121. Riley RL, Mills CC, O’Grady F, et al: Infectiousness of air from a tuberculosis ward. Am Rev Respir Dis 85: 511–525, 1962.

    PubMed  CAS  Google Scholar 

  122. Selwyn PA, Hartel D, Lewis VA, et al: A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320: 545–550, 1989.

    PubMed  CAS  Google Scholar 

  123. Hoy JF, Rolston KVI, Hopfer RL, et al: Mycobacterium fortuitum bacteremia in patients with cancer and long-term venous catheters. Am J Med 83: 213–217, 1987.

    PubMed  CAS  Google Scholar 

  124. Wilson WEC, Kirpatrick CH, Talmage DW: Suppression of immunologic responsiveness in uremia. Ann Intern Med 62: 1–14, 1965.

    Google Scholar 

  125. Selroos O, Pasternack A, Virolainen M: Skin test sensitivity and antigen-induced lymphocyte transformation in uremia. Clin Exp Immunol 14: 365–370, 1973.

    PubMed  CAS  Google Scholar 

  126. Pradhan RP, Katz LA, Nidus BD, et al: Tuberculosis in dialyzed patients. JAMA 229: 798–800, 1974.

    PubMed  CAS  Google Scholar 

  127. Andrew OT, Schoenfeld PY, Hopewell PC at al: Tuberculosis in patients with end-stage renal disease. Am J Med 68: 59–65, 1980.

    PubMed  CAS  Google Scholar 

  128. CDC: Nontuberculous mycobacterial infections in hemodialysis patients. Morb Mortal Wkly Rep 32: 244–246, 1983.

    Google Scholar 

  129. Band JD, Ward JI, Fraser DW, et al: Peritonitis due to a Mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. J Infect Dis 145: 9–17, 1982.

    PubMed  CAS  Google Scholar 

  130. Scroggs MW, Wolfe JA, Bollinger RR, et al: Causes of death in renal transplant recipients: A review of autopsy findings from 1966 through 1985. Arch Pathol Lab Med 111: 983–987, 1987.

    PubMed  CAS  Google Scholar 

  131. Oh C-S, Stratta RJ, Fox BC, et al: Increased infections associated with the use of OKT3 for treatment of steroid-resistant rejection in renal transplantation. Transplantation 45: 68–73, 1988.

    PubMed  CAS  Google Scholar 

  132. Thomas PA, Manko MA: Chemoprophylaxis for the prevention of tuberculosis in the immunosuppressed renal allograft recipient. Transplantation 20: 76–77, 1975.

    PubMed  Google Scholar 

  133. Lie TS, Hofer M: Tuberkulose nach Lebertransplantation. Dtsch Med Wochenschr 113: 731–734, 1988.

    PubMed  CAS  Google Scholar 

  134. Kurzrock R, Zander A, Vellekoop L, et al: Mycobacterial pulmonary infections after allogeneic bone marrow transplantation. Am J Med 77: 35–40, 1984.

    PubMed  CAS  Google Scholar 

  135. Trulock EP, Bolman RM, Genton R: Pulmonary disease caused by Mycobacterium chelonae in a heart-lung transplant recipient with obliterative bronchiolitis. Am Rev Respir Dis 140: 802–805, 1989.

    PubMed  CAS  Google Scholar 

  136. Neff TA, Hudgel DW: Miliary tuberculosis in a renal transplant recipient. Am Rev Respir Dis 108: 677–678, 1973.

    PubMed  CAS  Google Scholar 

  137. Lloveras, J, Peterson PK, Simmons RL, et al: Mycobacterial infections in renal transplant recipients: Seven cases and a review of the literature. Arch Intern Med 142: 888–892, 1982.

    PubMed  CAS  Google Scholar 

  138. Lichtenstein IH, MacGregor RR: Mycobacterial infections in renal transplant recipients: Report of five cases and review of the literature. Rev Infect Dis 5: 216–226, 1983.

    PubMed  CAS  Google Scholar 

  139. Spence RK, Dafoe DC, Rabin G, et al: Mycobacterial infections in renal allograft recipients. Arch Surg 118: 356–359, 1983.

    PubMed  CAS  Google Scholar 

  140. Gueco I, Saniel M, Mendoza M, et al: Tropical infections after renal transplantation. Transplant Proc 21: 2105–2107, 1989.

    PubMed  CAS  Google Scholar 

  141. Riska H, Kuhlback B: Tuberculosis and kidney transplantation. Acta Med Scand 205: 637–640, 1979.

    PubMed  CAS  Google Scholar 

  142. Lenk S, Oesterwitz H, Scholz D: Tuberculosis in cadaveric renal allograft recipients: Report of 4 cases and review of the literature. Eur Urol 14: 484–486, 1988.

    PubMed  CAS  Google Scholar 

  143. Gombert ME, Goldstein EJC, Corrado ML, et al: Disseminated Mycobacterium marinum infection after renal transplantation. Ann Intern Med 94: 486–487, 1981.

    PubMed  CAS  Google Scholar 

  144. Fraser DW, Buxton AE, Naji A, et al: Disseminated Mycobacterium Kansasii infection presenting as cellulitis in a recipient of a renal homograft. Am Rev Respir Dis 112: 125–129, 1975.

    PubMed  CAS  Google Scholar 

  145. Graybill JR, Silva J, Fraser DW, et al: Disseminated mycobacteriosis die to Mycobacterium abscessus in two recipients of renal homografts. Am Rev Respir Dis 109: 4–10, 1974.

    PubMed  CAS  Google Scholar 

  146. Cooper JF, Lichtenstein MJ, Graham BS, et al: Mycobacterium chelonae: A cause of nodular skin lesions with a proclivity for renal transplant recipients. Am J Med 86: 173–177, 1989.

    PubMed  CAS  Google Scholar 

  147. Davis BR, Brumbach J, Sanders WJ, et al: Skin lesions caused by Mycobacterium haemophilum. Ann Intern Med 97: 723–724, 1982.

    PubMed  CAS  Google Scholar 

  148. Mansour AM: Renal allograft tuberculosis. Tubercle 71: 147–148, 1990.

    PubMed  CAS  Google Scholar 

  149. Snider DE: The relationship between tuberculosis and silicosis. Am Rev Respir Dis 118: 455–460, 1978.

    PubMed  Google Scholar 

  150. Allison AC, D’Arcy Hart P: Potentiation by silica of the growth of Mycobacterium tuberculosis in macrophage cultures. Br J Exp Pathol 49: 465–476, 1968.

    PubMed  CAS  Google Scholar 

  151. Thorn PA, Brookes VS, Waterhouse JAH: Peptic ulcer, partial gastrectomy, and pulmonary tuberculosis. Br Med J 1: 603–608, 1956.

    PubMed  CAS  Google Scholar 

  152. Snider DE: Jejunoileal bypass for obesity: A risk factor for tuberculosis. Chest 81: 31–32, 1982.

    Google Scholar 

  153. McMurray DN, Bartow RA, Mintzer CL: Impact of protein malnutrition on exogenous reinfection with Mycobacterium tuberculosis. Infect Immun 57: 1746–1749, 1985.

    Google Scholar 

  154. Cohen MK, Bartwo RA, Mintzer CL, et al: Effects of diet and genetics on Mycobacterium bovis BCG vaccine efficacy in inbred guinea pigs. Infect Immun 55: 314–319, 1987.

    PubMed  CAS  Google Scholar 

  155. McMurray DN, Yetley EA: Cell-mediated immunity in malnourished guinea pigs after Mycobacterium bovis BCG vaccination. Infect Immun 35: 909–914, 1982.

    PubMed  CAS  Google Scholar 

  156. McMurray DN, Carlomagno MA, Mintzer CL, et al: Mycobacterium bovis BCG vaccine fails to protect protein-deficient guinea pigs against respiratory challenge with virulent Mycobacterium tuberculosis. Infect Immun 50: 555–559, 1985.

    PubMed  CAS  Google Scholar 

  157. MacCuish AC, Urbaniak SJ, Campbell CJ, et al: Phytohemagglutinin transformation and a circulating lymphocyte subpopulation in insulin-dependent diabetic patients. Diabetes 23: 708–712, 1974.

    PubMed  CAS  Google Scholar 

  158. Hudolin V: Tuberculosis and alcoholism. Ann NY Acad Sci 252: 353–364, 1975.

    PubMed  CAS  Google Scholar 

  159. Mendenhall CL, Grossman CJ, Roselle GA, et al: Host response to mycobacterial infection in the alcoholic rat. Gastroenterology 99: 1723–1726, 1990.

    PubMed  CAS  Google Scholar 

  160. MacGregor RR: Alcohol and immune defense. JAMA 256: 1474–1479, 1986.

    PubMed  CAS  Google Scholar 

  161. Bermudez LE, Young LS: Ethanol augments intracellular survival of Mycobacterium avium complex and impairs macrophage responses to cytokines. J Infect Dis 163: 1286–1292, 1991.

    PubMed  CAS  Google Scholar 

  162. Nardell E, McInnis, B, Thomas B, et al: Exogenous reinfection with tuberculosis in a shelter for the homeless. N Engl J Med 315: 1570–1575, 1986.

    PubMed  CAS  Google Scholar 

  163. Schieffelbein CW, Snider DE: Tuberculosis control among homeless populations. Arch Intern Med 148: 1843–1846, 1988.

    PubMed  Google Scholar 

  164. Joris F, Girard JP: Immune response in aged and young subjects following administration of large doses of tuberculin. Int Arch Allergy Appl Immunol 48: 584–596, 1975.

    PubMed  CAS  Google Scholar 

  165. Gardner ID: The effect of aging on susceptibility to infection. Rev Infect Dis 2: 801–810, 1980.

    PubMed  CAS  Google Scholar 

  166. Stead WW, Lofgren JP: Does the risk of tuberculosis increase in old age?. J Infect Dis 147: 951–955, 1983.

    PubMed  CAS  Google Scholar 

  167. Stead WW, Lofgren JP, Warren E, et al: Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Engl J Med 312: 1483–1487, 1985.

    PubMed  CAS  Google Scholar 

  168. Narain JP, Lofgren JP, Warren E, et al: Epidemic tuberculosis in a nursing home: A retrospective cohort study. J Am Geriatr Soc 33: 258–263, 1985.

    PubMed  CAS  Google Scholar 

  169. Sunderam G, McDonald RJ, Maniatis T, et al: Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS). JAMA 256: 362–366, 1986.

    PubMed  CAS  Google Scholar 

  170. Young LS, Inderlied CB, Berlin OG, et al: Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex. Rev Infect Dis 8: 1024–1033, 1986.

    PubMed  CAS  Google Scholar 

  171. CDC: Diagnosis and management of mycobacterial infection and disease in persons with human immunodeficiency virus infection. Morb Mortal Wkly Rep 35: 448–452, 1986.

    Google Scholar 

  172. Snider DE, Hopewill PC, Mills J, et al: Mycobacterioses and the acquired immunodeficiency syndrome. Am Rev Respir Dis 136: 492–496, 1987.

    Google Scholar 

  173. Chaisson RE, Schecter GF, Theuer CP, et al: Tuberculosis in patients with the acquired immunodeficiency syndrome: Clinical features, response to therapy, and survival. Am Rev Respir Dis 136: 570–574, 1987.

    PubMed  CAS  Google Scholar 

  174. Pitchenik AE, Fertel D, Bloch AB: Mycobacterial disease: Epidemiology, diagnosis, treatment, and prevention. Clin Chest Med 9: 425–441, 1988.

    PubMed  CAS  Google Scholar 

  175. Chaisson RE, Slutkin G: Tuberculosis and human immunodeficiency virus infection. J Infect Dis 159: 96–100, 1989.

    PubMed  CAS  Google Scholar 

  176. Modilevsky T, Sattler FR, Barnes PF: Mycobacterial disease in patients with human immunodeficiency virus infection. Arch Intern Med 149: 2201–2205, 1989.

    PubMed  CAS  Google Scholar 

  177. Rieder HL, Cauthen GM, Kelly GD, et al: Tuberculosis in the United States. JAMA 262: 385–389, 1989.

    PubMed  CAS  Google Scholar 

  178. Braun MM, Byers RB, Heyward WL, et al: Acquired immunodeficiency syndrome and extrapulmonary tuberculosis in the United States. Arch Intern Med 150: 1913–1916, 1990.

    PubMed  CAS  Google Scholar 

  179. Horsburgh, CR: Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 324: 1332–1338, 1991.

    PubMed  Google Scholar 

  180. Ellner JJ, Goldberger MJ, Parenti DM: Mycobacterium avium infection and AIDS: A therapeutic dilemma in rapid evolution. J Infect Dis 163: 1326–1335, 1991.

    PubMed  CAS  Google Scholar 

  181. Barnes PF, Bloch AB, Davidson PT, et al: Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 324: 1644–1650, 1991.

    PubMed  CAS  Google Scholar 

  182. CDC: Update tuberculosis elimination—United States. Morb Mortal Wkly Rep 39: 153–156, 1990.

    Google Scholar 

  183. Harries AD: Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet 335: 387–390, 1990.

    PubMed  CAS  Google Scholar 

  184. Bloch AB, Rieder HL, Kelly GD, et al: The epidemiology of tuberculosis in the United States. Semin Respir Infect 4: 157–170, 1989.

    PubMed  CAS  Google Scholar 

  185. Pitchenik AE, Cole C, Russell BW, et al: Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida. Ann Intern Med 101: 641–645, 1984.

    PubMed  CAS  Google Scholar 

  186. Rieder HL, Cauthen GM, Bloch AB, et al: Tuberculosis and acquired immunodeficiency syndrome—Florida. Arch Intern Med 149: 1268–1273, 1989.

    PubMed  CAS  Google Scholar 

  187. CDC: Tuberculosis and human immunodeficiency virus infection: Recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). Morb Mortal Wkly Rep 38: 236–238, 243-250, 1989.

    Google Scholar 

  188. Bender BS, Davidson BL, Kline R, et al: Role of the mono-nuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Rev Infect Dis 10: 1142–1154, 1988.

    PubMed  CAS  Google Scholar 

  189. Theuer CP, Hopewill PC, Elias D, et al: Human immunodeficiency virus infection in tuberculosis patients. J Infect Dis 162: 8–12, 1990.

    PubMed  CAS  Google Scholar 

  190. Pitchenik AE, Burr J. Suarez M, et al: Human T-cell lymphotropic virus-III (HTLV-III) seropositivity and related disease among 71 consecutive patients in whom tuberculosis was diagnosed: A prospective study. Am Rev Respir Dis 135: 875–879, 1987.

    PubMed  CAS  Google Scholar 

  191. Kramer F, Modilevsky T, Waliany AR, et al: Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infections. Am J Med 89: 451–456, 1990.

    PubMed  CAS  Google Scholar 

  192. CDC: Tuberculosis and acquired immunodeficiency syndrome— New York City. Morb Mortal Wkly Rep 36: 785–790, 795, 1987.

    Google Scholar 

  193. Handwerger S, Mildvan D, Senie R, et al: Tuberculosis and the acquired immunodeficiency syndrome at a New York City hospital: 1978–1985. Chest 91: 176–180, 1987.

    PubMed  CAS  Google Scholar 

  194. Louie E, Rice LB, Holzman RS: Tuberculosis in non-Haitian patients with acquired immunodeficiency syndrome. Chest 90: 542–545, 1986.

    PubMed  CAS  Google Scholar 

  195. Shafer RW, Goldberg R, Sierra M, et al: Frequency of Mycobacterium tuberculosis bacteremia in patients with tuberculosis in an area endemic for AIDS. Am Rev Respir Dis 140: 1611–1613, 1989.

    PubMed  CAS  Google Scholar 

  196. Barber TW, Craven DE, McCabe WR: Bacteremia due to My-cobacterium tuberculosis: A report of nine cases and a review of the literature. Medicine (Baltimore) 69: 375–383, 1990.

    CAS  Google Scholar 

  197. Pitchenik AE, Rubinson HA: The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis 131: 393–396, 1985.

    PubMed  CAS  Google Scholar 

  198. CDC: The use of preventive therapy for tuberculous infection in the United States: Recommendations of the Advisory Committee for Elimination of Tuberculosis. Morb Mortal Wkly Rep 39(RR-8): 9–12, 1990.

    Google Scholar 

  199. CDC: Purified protein derivative (PPD)-tuberculin anergy and HIV infection: Guidelines for anergy testing and management of anergic persons at risk of tuberculosis. Morb Mortal Wkly Rep 40(RR-5): 27–33, 1991.

    Google Scholar 

  200. Klein NC, Cuncanson FP, Lenox TH, et al: Use of mycobacterial smears in the diagnosis of pulmonary tuberculosis in AIDS/ARC patients. Chest 95: 1190–1192, 1989.

    PubMed  CAS  Google Scholar 

  201. Horsburgh CR, Selik RM: The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis 139: 4–7, 1989.

    PubMed  Google Scholar 

  202. Greene JB, Sidhu GS, Lewin S, et al: Mycobacterium avium-intracellulare: A cause of disseminated life-threatening infection in homosexuals and drug abusers. Ann Intern Med 97: 539–546, 1982.

    PubMed  CAS  Google Scholar 

  203. Fainstein V, Bolivar R, Mavligit G, et al: Disseminated infection due to Mycobacterium avium-intracellulare in a homosexual man with Kaposi’s sarcoma. J Infect Dis 145: 586, 1982.

    PubMed  CAS  Google Scholar 

  204. Zakowski P, Fligiel S, Berlin OGW, et al: Disseminated Mycobacterium avium-intracellulare infection in homosexual men dying of acquired immunodeficiency. JAMA 248: 2980–2982, 1982.

    PubMed  CAS  Google Scholar 

  205. Macher AM, Kovacs JA, Gill V, et al: Bacteremia due to Mycobacterium avium—intracellulare in the acquired immunodeficiency syndrome. Ann Intern Med 99: 782–785, 1983.

    PubMed  CAS  Google Scholar 

  206. Wong B, Edwards FF, Kiehn TE, et al: continuous high-grade Mycobacterium avium—intracellulare bacteremia in patients with the acquired immune deficiency syndrome. Am J Med 78: 35–40, 1985.

    PubMed  CAS  Google Scholar 

  207. Reichert CM, O’Leary TJ, Levens DL, et al: Autopsy pathology in the acquired immune deficiency syndrome. Am J Pathol 112: 357–382, 1983.

    PubMed  CAS  Google Scholar 

  208. Welch K, Finkbeiner W, Alpers CE, et al: Autopsy findings in the acquired immune deficiency syndrome. JAMA 252: 1152–1159, 1984.

    PubMed  CAS  Google Scholar 

  209. Klatt EC, Jensen DF, Meyer PR: Pathology of Mycobacterium avium—intracellulare infection in acquired immunodeficiency syndrome. Hum Pathol 18: 709–714, 1987.

    PubMed  CAS  Google Scholar 

  210. Hawkins CC, Gold JWM, Whimbey E, et al: Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 105: 184–188, 1986.

    PubMed  CAS  Google Scholar 

  211. Wallace JM, Hannah JB: Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome: A clinicopathologic study. Chest 93: 926–932, 1988.

    PubMed  CAS  Google Scholar 

  212. Hoy J, Mijch A, Sandland M, et al: Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients. J Infect Dis 161: 801–805, 1990.

    PubMed  CAS  Google Scholar 

  213. Guthertz LS, Damsker B, Bottone EJ, et al: Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS. J. Infect Dis 160: 1037–1041, 1989.

    PubMed  CAS  Google Scholar 

  214. Horsburgh CR, Cohn DL, Roberts RB, et al: Mycobacterium avium—Mycobacterium intracellulare isolates from patients with or without acquired immunodeficiency syndrome. Antimicrob Agents Chemother 30: 955–957, 1986.

    PubMed  CAS  Google Scholar 

  215. Yakrus MA, Good RC: Geographic distribution, frequency, and specimen source of Mycobacterium avium complex serotypes isolated from patients with acquire immunodeficiency syndrome. J Clin Microbiol 28: 926–929, 1990.

    PubMed  CAS  Google Scholar 

  216. Hampson SJ, Thompson J, Moss MT, et al: DNA probes demonstrate a single highly conserved strain of Mycobacterium avium infecting AIDS patients. Lancet 1: 65–68, 1989.

    PubMed  CAS  Google Scholar 

  217. Gangadharam PRJ, Perumal VK, Crawford JT, et al: Association of plasmids and virulence of Mycobacterium avium complex. Am Rev Respir Dis 137: 212–214, 1988.

    PubMed  CAS  Google Scholar 

  218. Damsker B, Bottone EJ: Mycobacterium avium-Mycobacterium intracellulare from the intestinal tracts of patients with the acquired immunodeficiency syndrome: Concepts regarding acquisition and pathogenesis. J Infect Dis 151: 179–181, 1985.

    PubMed  CAS  Google Scholar 

  219. Kiehn TE, Edwards FF, Brannon P, et al: Infections caused by Mycobacterium avium complex in immunocompromised patients: Diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics. J Clin Microbiol 21: 168–173, 1985.

    PubMed  CAS  Google Scholar 

  220. Stacey AR: Isolation of Mycobacterium avium—intracellulare— scrofulaceum complex from faeces of patients with AIDS. Br Med J 293: 1194, 1986.

    CAS  Google Scholar 

  221. Tenholder MF, Moser RJ, Tellis CJ: Mycobacteria other than tuberculosis: Pulmonary involvement in patients with acquired immunodeficiency syndrome. Arch Intern Med 148: 953–955, 1988.

    PubMed  CAS  Google Scholar 

  222. Horsburgh CR: Mycobacterium avium complex infections in the acquired immunodeficiency syndrome. N Engl J Med 324: 1332–1338, 1991.

    PubMed  Google Scholar 

  223. Ellner JJ, Goldberger MJ, Parenti DM: Mycobacterium avium infection and AIDS: A therapeutic dilemma in rapid evolution. J Infect Dis 163: 1326-1335.

    Google Scholar 

  224. Crowle AJ, Cohn DL, Poche P: Defects in sera from acquired immunodeficiency syndrome (AIDS) patients and from non-AIDS patients with Mycobacterium avium infection which decrease macrophage resistance to M. avium. Infect Immun 57: 1445–1451, 1989.

    PubMed  CAS  Google Scholar 

  225. Young LS: Mycobacterium avium complex infection. J Infect Dis 157: 863–867, 1988.

    PubMed  CAS  Google Scholar 

  226. Barnes PF, Arevalo C: Blood culture positivity patterns in bacteremia due to Mycobacterium avium—intracellulare. South Med J 81: 1059–1060, 1988.

    PubMed  CAS  Google Scholar 

  227. Small PM, Schecter GF, Goodman PC, et al: Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med 324: 289–294, 1991.

    PubMed  CAS  Google Scholar 

  228. Snider DE, Cohn DL, Davidson PT, et al: Standard therapy for tuberculosis. Chest 87: 117S–124S, 1985.

    PubMed  Google Scholar 

  229. Bass JB, Hawkins EL: Treatment of disease caused by non-tuberculous mycobacteria. Arch Intern Med 143: 1439–1441, 1983.

    PubMed  Google Scholar 

  230. Etzkorn ET, Aldarondo S, McAllister CK, et al: Medical therapy of Mycobacterium avium-intracellulare pulmonary disease. Am Rev Respir Dis 134: 442–445, 1986.

    PubMed  CAS  Google Scholar 

  231. Tsukamura M: Evidence that antituberculosis drugs are really effective in the treatment of pulmonary infection caused by Mycobacterium avium complex. Am Rev Respir Dis 137: 144–148, 1988.

    PubMed  CAS  Google Scholar 

  232. Masur H, Tuazon C, Gill V, et al: Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. J Infect Dis 155: 127–129, 1987.

    PubMed  CAS  Google Scholar 

  233. Bach MC: Treating disseminated Mycobacterium avium-intracellulare infection. Ann Intern Med 110: 169, 1989.

    PubMed  CAS  Google Scholar 

  234. Agins BD, Berman DS, Spicehandler D, et al: Effect of combined therapy with ansamycin, clofazimine, ethambutol and isoniazid for Mycobacterium avium infection in patients with AIDS. J Infect Dis 159: 784–787, 1989.

    PubMed  CAS  Google Scholar 

  235. Benson CA, Kessler HA, Pottage JC, et al: Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin. Arch Intern Med 151: 582–585, 1991.

    PubMed  CAS  Google Scholar 

  236. Chiu J, Nussbaum J, Bozzette S, et al: Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. Ann Intern Med 113: 358–361, 1990.

    PubMed  CAS  Google Scholar 

  237. Hoy J, Mijch A, Sandland M, et al: Quadruple-drug therapy for Mycobacterium avium—intracellulare bacteremia in AIDS patients. J Infect Dis 161: 801–805, 1990.

    PubMed  CAS  Google Scholar 

  238. Robboy SJ, Vickery AL: Tinctorial and morphologic properties distinguishing actinomycosis and nocardiosis. N Engl J Med 282: 593–596, 1970.

    PubMed  CAS  Google Scholar 

  239. Land G, McGinnis MR, Staneck J, et al: Aerobic pathogenic actinomycetales. In Balows A, Hausler WJ Jr, Herrmann KL, et al (eds): Manual of Clinical Microbiology, 5th ed. American Society for Microbiology, Washington, D.C., 1991, pp. 340–359.

    Google Scholar 

  240. Beaman BL, Burnside J, Edwards B, et al: Nocardial infections in the United States, 1972-1974. J Infect Dis 134: 286–289, 1976.

    PubMed  CAS  Google Scholar 

  241. Stevens DA, Pier AC, Beaman BL, et al: Laboratory evaluation of an outbreak of nocardiosis in immunocompromised hosts. Am J Med 71: 928–934, 1981.

    PubMed  CAS  Google Scholar 

  242. Simpson GL, Raffin TA, Remington JS: Association of prior nocardiosis and subsequent occurrence of nontuberculous my-cobacteriosis in a defined, immunosuppressed population. J Infect Dis 146: 211–219, 1982.

    PubMed  CAS  Google Scholar 

  243. Simpson GL, Stinson EB, Egger MJ, et al: Nocardial infections in the immunocompromised host: A detailed study in a defined population. Rev Infect Dis 3: 492–507, 1981.

    PubMed  CAS  Google Scholar 

  244. Houang ET, Lovett IS, Thompson FD, et al: Nocardia asteroides infection—a transmissible disease. J Hosp Infect 1: 31–40, 1980.

    PubMed  CAS  Google Scholar 

  245. Beaman BL, Sugar AM: Nocardia in naturally acquired and experimental infections in animals. J Hyg Cambridge 91: 393–419, 1983.

    CAS  Google Scholar 

  246. Sundararaj T, Agarwal SC: Cell-mediated immunity in experimental Nocardia asteroides infection. Infect Immun 15: 370–375, 1977.

    PubMed  CAS  Google Scholar 

  247. Sundararaj T, Agarwal SC: Relationship of macrophages to cell-mediated immunity in experimental Nocardia asteroides infection. Infect Immun 20: 685–691, 1978.

    PubMed  CAS  Google Scholar 

  248. Hiramine C, Hojo K, Yano I: Development of cell-mediated hypersensitivity in guinea pigs following infection with Nocardia asteroides. Int Arch Allergy Appl Immunol 65: 220–234, 1981.

    PubMed  CAS  Google Scholar 

  249. Ortiz-Ortiz L, Contreras MF, Bojalil LF: Cytoplasmic antigens from Nocardia eliciting a specific delayed hypersensitivity. Infect Immun 5: 879–882, 1972.

    PubMed  CAS  Google Scholar 

  250. Folb PI, Timme A, Horowitz A: Nocardia infections in congenitally athymic (nude) mice and in other inbred mouse strains. Infect Immun 18: 459–466, 1977.

    PubMed  CAS  Google Scholar 

  251. Beaman BL, Gershwin ME, Maslan S: Infectious agents in immunodeficient murine models: Pathogenicity of Nocardia asteroides in congenitally athymic (nude) and hereditarily asplenic (Dh/+) mice. Infect Immun 20: 381–387, 1978.

    PubMed  CAS  Google Scholar 

  252. Filice GA, Beaman BL, Remington JS: Effects of activated macrophages on Nocardia asteroides. Infect Immun 27: 643–649, 1980.

    PubMed  CAS  Google Scholar 

  253. Deem RL, Beaman BL, Gershwin ME: Adoptive transfer of immunity to Nocardia asteroides in nude mice. Infect Immun 38: 914–920, 1982.

    PubMed  CAS  Google Scholar 

  254. Kim J. Minamoto GY, Grieco MH: Nocardial infection as a complication of AIDS: Report of six cases and review. Rev Infect Dis 13: 624–629, 1991.

    PubMed  CAS  Google Scholar 

  255. Beaman BL, Maslan S: Effect of cyclophosphamide on experimental Nocardia asteroides infection in mice. Infect Immun 16: 995–1004, 1977.

    PubMed  CAS  Google Scholar 

  256. Mishra SK, Sandhu RS, Randhawa HS, et al: Effect of cortisone administration on experimental nocardiosis. Infect Immun 7: 123–129, 1973.

    PubMed  CAS  Google Scholar 

  257. Beaman BL: In vitro response of rabbit alveolar macrophages to infection with Nocardia asteroides. Infect Immun 15: 925–937, 1977.

    PubMed  CAS  Google Scholar 

  258. Davis-Scibienski C, Beaman BL: Interaction of alveolar macrophages with Nocardia asteroides: Immunological enhancement of phagocytosis, phagosome-lysosome fusion, and microbicidal activity. Infect Immun 30: 578–587, 1980.

    PubMed  CAS  Google Scholar 

  259. Beaman BL, Smathers M: Interaction of Nocardia asteroides with cultured rabbit alveolar macrophages. Infect Immun 13: 1126–1131, 1976.

    PubMed  CAS  Google Scholar 

  260. Beaman BL: Interaction of Nocardia asteroides at different phases of growth with in vitro-maintained macrophages obtained from the lungs of normal and immunized rabbits. Infect Immun 26: 355–361, 1979.

    PubMed  CAS  Google Scholar 

  261. Filice GA, Niewoehner DE: Contribution of neutrophils and cell-mediated immunity to control of Nocardia asteroides in murine lungs. J Infect Dis 156: 113–120, 1987.

    PubMed  CAS  Google Scholar 

  262. Filice GA, Beaman BL, Krick JA, et al: Effects of human neutrophils and monocytes on Nocardia asteroides: Failure of killing despite occurrence of the oxidative metabolic burst. J Infect Dis 142: 432–438, 1980.

    PubMed  CAS  Google Scholar 

  263. Filice GA: Resistance of Nocardia asteroides to oxygen-dependent killing by neutrophils. J Infect Dis 148: 861–867, 1983.

    PubMed  CAS  Google Scholar 

  264. Filice GA: Inhibition of Nocardia asteroides by neutrophils. J Infect Dis 151: 47–56, 1985.

    PubMed  CAS  Google Scholar 

  265. Beaman BL, Black CM, Doughty F, et al: Role of Superoxide dismutase and catalase as determinants of pathogenicity of Nocardia asteroides: Importance in resistance to microbicidal activities of human polymorphonuclear neutrophils. Infect Immun 47: 135–141, 1985.

    PubMed  CAS  Google Scholar 

  266. Deem RL, Doughty FA, Beaman BL: Immunologically specific direct T lymphocyte-mediated killing of Nocardia asteroides. J Immunol 130: 2401–2406, 1983.

    PubMed  CAS  Google Scholar 

  267. Andriole VT, Ballas M, Wilson GL: The association of nocardiosis and pulmonary alveolar proteinosis: A case study. Ann Intern Med 60: 266–275, 1964.

    PubMed  CAS  Google Scholar 

  268. Carlsen ET, Hill RB, Rowlands DT: Nocardiosis and pulmonary alveolar proteinosis. Ann Intern Med 60: 275–281, 1964.

    PubMed  CAS  Google Scholar 

  269. Scheonbaum SC: Case records of the Massachusetts General Hospital (Case 18-1988). N Engl J Med 318: 1186–1194, 1988.

    Google Scholar 

  270. Bach MC, Adler JL, Breman J, et al: Influence of rejection therapy on fungal and nocardial infections in renal-transplant recipients. Lancet 1: 180–184, 1973.

    PubMed  CAS  Google Scholar 

  271. Krick JA, Stinson EB, Remington JS: Nocardia infection in heart transplant patients. Ann Intern Med 82: 18–26, 1975.

    PubMed  CAS  Google Scholar 

  272. Leaker B, Hellyar A, Neild GH, et al: Nocardia infection in a renal transplant unit. Transplant Proc 21: 2103–2104, 1989.

    PubMed  CAS  Google Scholar 

  273. Young LS, Armstrong D, Blevins A, et al: Nocardia asteroides infection complicating neoplastic disease. Am J Med 50: 356–367, 1971.

    PubMed  CAS  Google Scholar 

  274. Berkey P, Bodey GP: Nocardial infection in patients with neoplastic disease. Rev Infect Dis 11: 407–412, 1989.

    PubMed  CAS  Google Scholar 

  275. Gorevic PD, Katler El, Agus B: Pulmonary nocardiosis: Occurrence in men with systemic lupus erythematosus. Arch Intern Med 140: 361–363, 1980.

    PubMed  CAS  Google Scholar 

  276. Williams I: Clinicopathologic conference: Headache, mental status changes, and death in a 36-year-old woman with lupus. Am J Med 86: 94–102, 1989.

    Google Scholar 

  277. Natale RB, Yagoda A, Brown A, et al: Combined Pneumocystis carinii and Nocardia asteroides pneumonitis in a patient with an ACTH-producing carcinoid. Cancer 47: 2933–2935, 1981.

    PubMed  CAS  Google Scholar 

  278. Bonner JR, Alexander WJ, Dismukes WE, et al: Disseminated histoplasmosis in patients with the acquired immune deficiency syndrome. Arch Intern Med 144: 2178, 1984.

    PubMed  CAS  Google Scholar 

  279. Holtz HA, Lavery DP, Kapila R: Actinomycetales infection in the acquired immunodeficiency syndrome. Ann Intern Med 102: 203–205, 1985.

    PubMed  CAS  Google Scholar 

  280. Adair JC, Beck AC, Apfelbaum RI, et al: Nocardial cerebral abscess in the acquired immunodeficiency syndrome. Arch Neurol 44: 548–550, 1987.

    PubMed  CAS  Google Scholar 

  281. Rodriguez JL, Barrio JL, Pitchenik AE: Pulmonary nocardiosis in the acquired immunodeficiency syndrome: Diagnosis with bronchoalveolar lavage and treatment with non-sulphur containing drugs. Chest 90: 912–914, 1986.

    PubMed  CAS  Google Scholar 

  282. Rosett W, Hodges GR: Recent experiences with nocardial infections. Am J Med Sci 276: 279–285, 1978.

    PubMed  CAS  Google Scholar 

  283. Murray JF, Finegold SM, Froman S, et al: The changing spectrum of nocardiosis: A review and presentation of nine cases. Am Rev Respir Dis 83: 315–330, 1961.

    PubMed  CAS  Google Scholar 

  284. Saltzman HA, Chick EW, Conant NF: Nocardiosis as a complication of other diseases. Lab Invest 11: 1110–1117, 1962.

    PubMed  CAS  Google Scholar 

  285. Palmer DL, Harvey RL, Wheeler JK: Diagnostic and therapeutic considerations in Nocardia asteroides infection. Medicine 53: 391–401, 1974.

    PubMed  CAS  Google Scholar 

  286. Frazier AR, Rosenow EC, Roberts GD: Nocardiosis: A review of 25 cases occurring during 24 months. Mayo Clin Proc 50: 657–663, 1975.

    PubMed  CAS  Google Scholar 

  287. Curry WA: Human nocardiosis: A clinical review with selected case reports. Arch Intern Med 140: 818–826, 1980.

    PubMed  CAS  Google Scholar 

  288. Adair JC, Amber IJ, Johnston JM: Peritonsillar abscess caused by Nocardia asteroides. J Clin Microbiol 25: 2214–2215, 1987.

    PubMed  CAS  Google Scholar 

  289. Poland GA, Jorgensen CR, Sarosi GA: Nocardia asteroides pericarditis: Report of a case and review of the literature. Mayo Clin Proc 65: 819–824, 1990.

    PubMed  CAS  Google Scholar 

  290. Schulman LL, Enson Y: Case report: Nocardia pneumonitis and the adult respiratory distress syndrome. Am J Med Sci 293: 315–319, 1987.

    PubMed  CAS  Google Scholar 

  291. Humphreys DW, Crowder JG, White A: Serologie reactions to Nocardia antigens. Am J Med Sci 269: 323–326, 1975.

    PubMed  CAS  Google Scholar 

  292. Blumer SO, Kaufman L: Microimmunidiffusion test for nocardiosis. J Clin Microbiol 10: 308–312, 1979.

    PubMed  CAS  Google Scholar 

  293. Shainhouse JZ, Pier AC, Stevens DA: Complement fixation antibody test for human nocardiosis. J Clin Microbiol 8: 516–519, 1978.

    PubMed  CAS  Google Scholar 

  294. Boiron P, Provost F: Enzyme immunoassay on whole Nocardia asteroides cells for human nocardiosis. Serodiagn Immunother Infect Dis 2: 445–452, 1988.

    Google Scholar 

  295. Pier AC, Fitchner RE: Serologie typing of Nocardia asteroides by immunodiffusion. Am Rev Respir Dis 103: 698–707, 1971.

    PubMed  CAS  Google Scholar 

  296. El-Zaatari FA, Reiss E, Yakrus MA, et al: Monoclonal antibodies against isoelectrically focused Nocardia asteroides proteins characterized by the enzyme-linked immunoelectro-transfer blot method. Diagn Immunol 4: 97–106, 1986.

    PubMed  CAS  Google Scholar 

  297. Boiron P, Provost F: Use of partially purified 54-kilodalton antigen for diagnosis of nocardiosis by Western blot (Immunoblot) assay. J Clin Microbiol 28: 328–331, 1990.

    PubMed  CAS  Google Scholar 

  298. Sugar AM, Schoolnik GK, Stevens DA: Antibody response in human nocardiosis: Identification of two immunodominant culture filtrate antigens derived from Nocardia asteroides. J Infect Dis 151: 895–901, 1985.

    PubMed  CAS  Google Scholar 

  299. Angeles am, Sugar AM: Diagnosis of human nocardiosis with an enzyme immunoassay. J Infect Dis 155: 292–296, 1987.

    PubMed  CAS  Google Scholar 

  300. Angeles AM, Sugar AM: Identification of a common immunodominant protein in culture filtrates of 3 Nocardia species: Use in etiologic diagnosis of mycetoma. J Clin Microbiol 25: 2278–2280, 1987.

    PubMed  CAS  Google Scholar 

  301. Runyon EH: Nocardia asteroides: Studies of its pathogenicity and drug sensitivities. J Lab Clin Med 37: 713–720, 1951.

    PubMed  CAS  Google Scholar 

  302. Smego RA Jr, Moeller MB, Gallis HA: Trimethoprim-sulfamethoxazole therapy for Nocardia infections. Arch Intern Med 143: 711–718, 1983.

    PubMed  Google Scholar 

  303. Wallace RJ Jr, Septimus EJ, Williams TW, et al: Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia. Rev Infect Dis 4: 315–325, 1982.

    PubMed  CAS  Google Scholar 

  304. Filice GA, Simpson GL: Management of Nocardia infections. In Remington JS, Swartz MN (eds): Current Clinical Topics in Infectious Diseases, Vol 5. McGraw-Hill, New York, 1984, pp. 49–64.

    Google Scholar 

  305. Bennett JE, Jennings AE: Factors influencing susceptibility of Nocardia species to trimethoprim—sulfamethoxazole. Antimicrob Agents Chemother 13: 624–627, 1978.

    PubMed  CAS  Google Scholar 

  306. Wallace RJ Jr, Septimus EJ, Musher DM, et al: Disk diffusion susceptibility testing of Nocardia species. J Infect Dis 135: 568–576, 1977.

    PubMed  CAS  Google Scholar 

  307. Bach MC, Sabath LD, Finland M: Susceptibility of Nocardia asteroides to 45 antimicrobial agents in vitro. Antimicrob Agents Chemother 3: 1–8, 1973.

    PubMed  CAS  Google Scholar 

  308. Southern PM Jr, Kutscher AE, Ragsdale R, et al: Susceptibility in vitro of Nocardia species to antimicrobial agents. Diagn Microbiol Infect Dis 8: 119–122, 1987.

    PubMed  CAS  Google Scholar 

  309. Wallace RJ Jr, Steel LC, Sumter G, et al: Antimicrobial susceptibility patterns of Nocardia asteroides. Antimicrob Agents Chemother 32: 1776–1779, 1988.

    PubMed  CAS  Google Scholar 

  310. Gombert ME, Aulicino TM, duBouchet L, et al: Susceptibility of Nocardia asteroides to new quinolones and β-lactams. Antimicrob Agents Chemother 31: 2013–2014, 1987.

    PubMed  CAS  Google Scholar 

  311. Wallace RJ Jr, Nash DR, Johnson WK, et al: β-Lactam resistance in Nocardia brasiliensis is mediated by β-lactamase and reversed in the presence of clavulanic acid. J Infect Dis 156: 959–966, 1987.

    PubMed  CAS  Google Scholar 

  312. Kitzis MD, Gutmann L, Acar JF: In-vitro susceptibility of Nocardia asteroides to 21 β-lactam antibiotics, in combination with three β-lactamase inhibitors, and its relationship to the β-lactamase content. J Antimicrob Chemother 15: 23–30, 1985.

    PubMed  CAS  Google Scholar 

  313. Berkey P, Moore D, Rolston K: In vitro susceptibilities of Nocardia species to newer antimicrobial agents. Antimicrob Agents Chemother 32: 1078–1079, 1988.

    PubMed  CAS  Google Scholar 

  314. Gutmann L, Goldstein FW, Kitzis MD, et al: Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 β-lactams. Antimicrob Agents Chemother 23: 248–251, 1983.

    PubMed  CAS  Google Scholar 

  315. Dewsnup DH, Wright DN: In vitro susceptibility of Nocardia asteroides to 25 antimicrobial agents. Antimicrob Agents Chemother 25: 165–167, 1984.

    PubMed  CAS  Google Scholar 

  316. Dalovisio JR, Pankey GA: In vitro susceptibility of Nocardia asteroides to amikacin. Antimicrob Agents Chemother 13: 128–129, 1978.

    PubMed  CAS  Google Scholar 

  317. Wallace RJ Jr, Septimus EJ, Musher DM, et al: Treatment of experimental noeardiosis in mice: Comparison of amikacin and sulfonamide. J Infect Dis 140: 244–248, 1979.

    PubMed  CAS  Google Scholar 

  318. Gombert ME, duBouchet L, Aulicino TM, et al: Antimicrobial synergism in the therapy of experimental cerebral nocardiosis. J Atimicrob Chemother 23: 39–43, 1989.

    Google Scholar 

  319. Gombert ME, Aulicino TM, duBouchet L, et al: Therapy of experimental cerebral nocardiosis with imipenem, amikacin, trimethoprim-sulfamethoxazole, and minocycline. Antimicrob Agents Chemother 30: 270–273, 1986.

    PubMed  CAS  Google Scholar 

  320. Sugar AM, Chahal RS, Stevens DA: A cephalosporin active in vivo against Nocardia: Efficacy of cefotaxime in murine model of acute pulmonary noeardiosis. J Hyg Cambridge 91: 420–427, 1983.

    Google Scholar 

  321. Petersen EA, Nash ML, Mammana RB, et al: Minocycline treatment of pulmonary noeardiosis. JAMA 250: 930–932, 1983.

    PubMed  CAS  Google Scholar 

  322. Bach MC, Monaco AP, Finland M: Pulmonary noeardiosis: Therapy with minocycline and with erythromycin plus ampicillin. JAMA 224: 1378–1381, 1973.

    PubMed  CAS  Google Scholar 

  323. Wren MV, Savage AM, Alford RH: Apparent cure of intracranial Nocardia asteroides infection by minocycline. Arch Intern Med 139: 249–250, 1979.

    PubMed  CAS  Google Scholar 

  324. Norden CW, Ruben FL, Selker R: Nonsurgical treatment of cerebral noeardiosis. Arch Neurol 40: 594–595, 1983.

    PubMed  CAS  Google Scholar 

  325. Meier B, Metzger U, Muller F, et al: Successful treatment of a pancreatic Nocardia asteroides abscess with amikacin and surgical drainage. Antimicrob Agents Chemother 29: 150–151, 1986.

    PubMed  CAS  Google Scholar 

  326. Goldstein FW, Hautefort B, Acar JF: Amikacin-containing regimens for treatment of noeardiosis in immunocompromised patients. Eur J Clin Microbiol 6: 198–200, 1987.

    PubMed  CAS  Google Scholar 

  327. Telzak EE, Hii J, Polsky B. et al: Nocardia infection in the acquired immunodeficiency syndrome. Diagn Microbiol Infect Dis 12: 517–519, 1989.

    PubMed  CAS  Google Scholar 

  328. Rivera JV, Perez JB: Pulmonary noeardiosis treated with chloramphenicol. Arch Intern Med 100: 152–156, 1957.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Boston University School of Medicine; The Thorndike Memorial Laboratory; and Department of Medicine, Boston City Hospital, Boston, Massachusetts, 02118, USA

    Thomas Barber

  2. Boston University School of Medicine; The Thorndike Memorial Laboratory; Department of Medicine, Boston City Hospital, Boston, Massachusetts, 02118, USA

    Alan M. Sugar

  3. Evans Memorial Department of Clinical Research and Department of Medicine, Boston University Medical Center, Boston, Massachusetts, 02118, USA

    Alan M. Sugar

Authors
  1. Thomas Barber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alan M. Sugar
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Massachusetts General Hospital, Boston, Massachusetts, USA

    Robert H. Rubin M.D. (Chief of Transplantation Infectious Disease, Director of the Center for Experimental Pharmacology and Therapeutics) (Chief of Transplantation Infectious Disease, Director of the Center for Experimental Pharmacology and Therapeutics)

  2. Division of Health Sciences and Technology, Harvard University-Massachusetts Institute of Technology, Cambridge, Massachusetts, USA

    Robert H. Rubin M.D. (Chief of Transplantation Infectious Disease, Director of the Center for Experimental Pharmacology and Therapeutics) (Chief of Transplantation Infectious Disease, Director of the Center for Experimental Pharmacology and Therapeutics)

  3. Pacific California Medical Center, San Francisco, California, USA

    Lowell S. Young M.D. (Director of Kuzell Institute for Arthritis and Infectious Diseases, Chief of Division of Infectious Diseases) (Director of Kuzell Institute for Arthritis and Infectious Diseases, Chief of Division of Infectious Diseases)

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Plenum Publishing Corporation

About this chapter

Cite this chapter

Barber, T., Sugar, A.M. (1994). Mycobacteriosis and Nocardiosis in the Immunocompromised Host. In: Rubin, R.H., Young, L.S. (eds) Clinical Approach to Infection in the Compromised Host. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2490-8_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2490-8_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-44617-7

  • Online ISBN: 978-1-4615-2490-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation